New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

XSTO Solutions Announces Exclusive US Distribution of BRUDY'S New DHA

XSTO SOLUTIONS, LLC (XSTO) and BRUDY TECHNOLOGY, S.L. (BRUDY), jointly announce a new sales and marketing distribution agreement between the two companies to market Algatrium®, BRUDY’S unique and patented source of DHA produced in Spain. With a growing global awareness and demand for DHA, BRUDY’S new Algatrium product is naturally produced and clinically tested. Algatrium’s DHA structure is the closest natural equivalent to the DHA found and utilized in the human body. This promotes enhanced bioavailability, nutritional benefit and efficacy.

“Using XSTO’S experience and relationships in the nutrition industry, we look forward to expanding the presence of our specialty ingredient line” stated Francesc Gassó, Managing Director of BRUDY.

“With multiple completed and ongoing clinical trials, Algatrium® DHA from BRUDY represents a major leap in technology for Omega 3 products. We are very pleased to bring this unique ingredient to our customer base” said Francis Foley, President of XSTO. “We look forward to aggressively promoting the presence of BRUDY and their unique “human-like” DHA ingredient in this booming area of nutrition” he added.
“The enhanced benefit of BRUDY’s specialized “second position” Triglyceride form of DHA will help support nutritional supplementation and healthier lives” confirmed Dan Murray, Vice President of Business Development at XSTO.

BRUDY TECHNOLOGY is a research and development (R&D) company founded in Barcelona in 1999 with 100% Spanish share capital. The main purpose of BRUDY TECHNOLOGY is to detect technology requirements in highly diverse sectors such as food, pharmaceutical or nutraceutical, among others. In recent years, BRUDY TECHNOLOGY has led major development projects and created new products in the polyunsaturated fatty acids field, a main area of specialization of the company. After an approximate investment of ten million Euros of self financing and eight years of university research, the company has researched the particularities of the DHA molecule on humans and has created ALGATRIUM, a revolutionary nutritional ingredient at an international level that slows down cell ageing and is a unique and optimal source of DHA of high bioavailability.

About XSTO Solutions
XSTO Solutions was established in 2004 and is headquartered in Morristown, New Jersey. XSTO’s core focus is bringing a small number of new science-supported nutritional ingredients to the functional food and dietary supplement markets. XSTO personnel have successfully and profitably launched new products, driving sales by acting as US-based sales and marketing partners. XSTO has also partnered with small-to medium-sized international ingredient manufacturers to increase sales and marketing focus. XSTO can be reached at 973.975.4224 or

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.